tradingkey.logo

Grail Inc

GRAL
86.360USD
+1.360+1.60%
收盤 10/28, 16:00美東報價延遲15分鐘
3.11B總市值
虧損本益比TTM

Grail Inc

86.360
+1.360+1.60%

關於 Grail Inc 公司

GRAIL, Inc.(前身爲 GRAIL, LLC)是一家醫療保健公司,致力於拯救生命並改變早期癌症檢測的範式。該公司專注於通過使用新一代測序、人口規模臨牀研究以及機器學習、軟件和自動化來在早期階段檢測和識別多種致命癌症類型,從而減輕全球癌症負擔。其基於靶向甲基化的平臺可以支持篩查和精準腫瘤學的連續護理,包括有症狀患者的多癌早期檢測、風險分層、微小殘留病檢測、生物標誌物亞型、治療和復發監測。其產品包括 Galleri 和 Beyond。Galleri 測試是一種市售的篩查測試,用於早期檢測多種類型的癌症,稱爲多癌早期檢測 (MCED)。Galleri 篩查測試結果可以幫助指導醫療保健提供者診斷癌症的下一步措施。

Grail Inc簡介

公司代碼GRAL
公司名稱Grail Inc
上市日期Jun 12, 2024
CEOMr. Robert (Bob) Ragusa
員工數量1000
證券類型Ordinary Share
年結日Jun 12
公司地址1525 O'brien Drive
城市MENLO PARK
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編94025
電話18336942553
網址https://grail.com/
公司代碼GRAL
上市日期Jun 12, 2024
CEOMr. Robert (Bob) Ragusa

Grail Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Aaron Freidin
Mr. Aaron Freidin
Chief Financial Officer
Chief Financial Officer
74.99K
-1.16%
Ms. Sarah Krevans
Ms. Sarah Krevans
Independent Director
Independent Director
68.19K
+9.79%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
12.32K
+3.57%
Mr. William J. (Bill) Chase
Mr. William J. (Bill) Chase
Independent Director
Independent Director
10.12K
+2.79%
Mr. Alex Dobbin
Mr. Alex Dobbin
IR Contact Officer
IR Contact Officer
--
--
Mr. Andy Partridge
Mr. Andy Partridge
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Robert (Bob) Ragusa
Mr. Robert (Bob) Ragusa
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Joshua (Josh) Ofman, M.D.
Mr. Joshua (Josh) Ofman, M.D.
President
President
--
--
Mr. Steve Mizell
Mr. Steve Mizell
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Aaron Freidin
Mr. Aaron Freidin
Chief Financial Officer
Chief Financial Officer
74.99K
-1.16%
Ms. Sarah Krevans
Ms. Sarah Krevans
Independent Director
Independent Director
68.19K
+9.79%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
12.32K
+3.57%
Mr. William J. (Bill) Chase
Mr. William J. (Bill) Chase
Independent Director
Independent Director
10.12K
+2.79%
Mr. Alex Dobbin
Mr. Alex Dobbin
IR Contact Officer
IR Contact Officer
--
--
Mr. Andy Partridge
Mr. Andy Partridge
Chief Commercial Officer
Chief Commercial Officer
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
業務USD
名稱
營收
佔比
Screening
34.38M
96.72%
Development Services
1.17M
3.28%
地區USD
名稱
營收
佔比
United States
34.21M
96.24%
International
1.34M
3.76%
業務
地區
業務USD
名稱
營收
佔比
Screening
34.38M
96.72%
Development Services
1.17M
3.28%

股東統計

更新時間: 10月17日 週五
更新時間: 10月17日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Illumina Inc
12.49%
BlackRock Institutional Trust Company, N.A.
5.78%
PRIMECAP Management Company
5.70%
The Vanguard Group, Inc.
5.26%
CRCM L.P.
5.00%
其他
65.77%
持股股東
持股股東
佔比
Illumina Inc
12.49%
BlackRock Institutional Trust Company, N.A.
5.78%
PRIMECAP Management Company
5.70%
The Vanguard Group, Inc.
5.26%
CRCM L.P.
5.00%
其他
65.77%
股東類型
持股股東
佔比
Investment Advisor
26.94%
Investment Advisor/Hedge Fund
24.96%
Hedge Fund
13.20%
Corporation
12.49%
Research Firm
2.58%
Individual Investor
1.31%
Bank and Trust
0.51%
Pension Fund
0.33%
Family Office
0.18%
其他
17.51%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
919
24.74M
68.62%
-5.55M
2025Q2
874
30.08M
83.61%
-1.68M
2025Q1
859
29.51M
82.19%
-2.62M
2024Q4
810
31.24M
92.16%
+4.27M
2024Q3
748
27.13M
81.56%
+4.49M
2024Q2
646
27.14M
86.18%
+27.14M
2024Q1
2
135.00
0.00%
+135.00

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Illumina Inc
4.50M
12.49%
+4.50M
--
Jun 30, 2024
BlackRock Institutional Trust Company, N.A.
2.09M
5.78%
+969.56K
+86.91%
Jun 30, 2025
PRIMECAP Management Company
2.05M
5.7%
+2.71K
+0.13%
Jun 30, 2025
The Vanguard Group, Inc.
1.90M
5.26%
+402.62K
+26.97%
Jun 30, 2025
CRCM L.P.
1.84M
5.11%
-1.80M
-49.45%
Sep 30, 2025
Baker Bros. Advisors LP
1.63M
4.52%
--
--
Jun 30, 2025
AQR Capital Management, LLC
1.33M
3.69%
-6.55K
-0.49%
Jun 30, 2025
State Street Investment Management (US)
1.25M
3.46%
-20.25K
-1.60%
Jun 30, 2025
Arbiter Partners Capital Management, LLC
1.04M
2.88%
+12.86K
+1.25%
Jun 30, 2025
Sessa Capital
786.14K
2.18%
-721.93K
-47.87%
Jun 30, 2025
查看更多

持股ETF

更新時間: 10月6日 週一
更新時間: 10月6日 週一
機構名稱
佔比
Invesco Dorsey Wright Healthcare Momentum ETF
2.11%
ROBO Global Healthcare Technology & Innovation ETF
0.96%
Franklin Genomic Advancements ETF
0.65%
SPDR S&P Biotech ETF
0.33%
Invesco Dorsey Wright SmallCap Momentum ETF
0.27%
Invesco Russell 2000 Dynamic Multifactor ETF
0.25%
Direxion Daily S&P Biotech Bull 3X Shares
0.2%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.12%
Vanguard US Momentum Factor ETF
0.1%
查看更多
Invesco Dorsey Wright Healthcare Momentum ETF
佔比2.11%
ROBO Global Healthcare Technology & Innovation ETF
佔比0.96%
Franklin Genomic Advancements ETF
佔比0.65%
SPDR S&P Biotech ETF
佔比0.33%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0.27%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.25%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.2%
ProShares Ultra Nasdaq Biotechnology
佔比0.12%
Invesco Nasdaq Biotechnology ETF
佔比0.12%
Vanguard US Momentum Factor ETF
佔比0.1%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI